Long-standing malignant pancreatic carcinoid treated with octreotide

A male presented with a metastatic, plasma serotonin-secreting (high 5-HIAA in urine), malignant pancreatic carcinoid with a carcinoid-like syndrome, and was assessed using ultrasounds (US), computerized tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography (EUS) and Octreosc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revista española de enfermedades digestivas 2010-11, Vol.102 (11), p.662-666
1. Verfasser:	Varas-Lorenzo, M J
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Hormonal - therapeutic use Carcinoid Tumor - drug therapy Gastroenterology & Hepatology Geriatrics & Gerontology Humans Infectious Diseases Male Middle Aged Octreotide - therapeutic use Oncology Pancreatic Neoplasms - drug therapy Pathology Pharmacology & Pharmacy Radiology, Nuclear Medicine & Medical Imaging Surgery Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A male presented with a metastatic, plasma serotonin-secreting (high 5-HIAA in urine), malignant pancreatic carcinoid with a carcinoid-like syndrome, and was assessed using ultrasounds (US), computerized tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography (EUS) and Octreoscan; he sequentially received chemotherapy, interferon and octreotide, with long-term, 12-year survival after diagnosis. Given this unusual case, the second reported in our country, the overall literature is reviewed.
ISSN:	1130-0108
DOI:	10.4321/S1130-01082010001100009